Positive Living August–September 2004

The August–September 2004 issue of Positive Living, with reports from the International AIDS Conference in Bangkok, a look at diabetes in people with HIV, the National HIV Strategy, and more.

Access for all

The news from Bangkok is sobering. Twenty million people have died over 25 years, and yet there is no sign of a cure and little expectation of a vaccine any time soon. Treatments exist, and they work, but there are real barriers to making them available to the vast bulk of people who need them.

Cambodian PREP trial halted

A controversial Cambodian trial of tenofovir for pre-exposure prophylaxis (PREP) is unlikely to proceed after sex workers and the Cambodian government claimed the trial did not include adequate safeguards for the health and human rights of the participants.

'Entirely inadequate'

The Queensland AIDS Council (QuAC) says it will no longer be able to provide support services to people with HIV, after a decision by the state government to award a multi-million dollar HIV care and support contract to a religious organisation.

Pacific leaders adopt HIV strategy

HIV incidence at neonatal clinics in Papua New Guinea have reached levels similar to those seen in South Africa a decade ago, the 35th Pacific Forum was told in early August.

Bangkok AIDS Conference: Small steps

There isn’t a lot of Earth-shattering news to report from Bangkok, but as always there were numerous small developments. As PAUL KIDD explains, some of these small steps could develop into giant leaps.

Encouraging signs

After the last International AIDS Conference, held in Barcelona in 2002, I felt profoundly depressed. It just seemed to me that globally a very small amount of progress had been made in a fight against a problem that had got much worse. Furthermore there was little I could point to that suggested things were really going to change.

Involvement or tokenism?

Ten years after the adoption of the GIPA (Greater Involvement of People With AIDS) principles at the Paris AIDS Summit, HIV-positive people are still struggling to be heard. NAPWA President GABE McCARTHY reports from Bangkok.

Partners in spirit

With more than a hundred thousand people living with HIV, Indonesia faces an uphill struggle to roll out treatment, education and care programs. But an inspirational and dynamic national network of positive people is playing its part.

Fifth National Strategy: not just a piece of paper

With public consultations about to begin for the Fifth National HIV/AIDS Strategy, DAVID MENADUE explains the importance of this key document.

A growing problem

For many people, the word ‘diabetes’ conjures up images of insulin injections, highly restricted diets and, perhaps, that pale, sickly kid at school who wasn’t allowed to have any lollies or paddle pops. The reality is somewhat more complex.

You are what you eat

I have never quite understood the concept of an “HIV identity”. What does it mean to say that a virus in your body has so overwhelmed your life that it has become an essential part of who you are?

Backgrounder: HIV basics

The dog who gave his life so that Mark Latham could live

Pancreatitis is in the news. With opposition leader Mark Latham struck down by this painful condition, we look at the role of the pancreas and at HIV-related pancreatitis.

Complementary Therapies

Independent predictors

Have you ever felt really run down and fatigued but when you front up for the results of your three-monthly blood test the doctor says; "Everything’s fine! Your viral load is undetectable and your CD4s are great”?

Text size: A A A

From Positive Living, NAPWA's HIV news magazine, produced four times a year and distributed nationally.

cover image
AttachmentSizeType
PDF version1.51 MB2004-3.pdfPDF

You can read PL on this website, or pick up a free copy in your local gay and lesbian community newspaper. If you'd rather receive PL through the post, we are happy to provide a free subscription to positive people anywhere in Australia.

Positive Living is distributed with generous assistance from Gilead Sciences & GlaxoSmithKline.
Gilead and GlaxoSmithKline logos